Array BioPharma Inc (ARRY)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: ARRY Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2019-06-06	2019-06-04	PS Planned sale	Sandor Victor Chief Medical Officer	100,000 -32.3% 28.51 USD 2,851,000	100,000 -32.3%	28.51	USD 2,851,000
2019-06-03	2019-06-03	PS Planned sale	Sandor Victor Chief Medical Officer	36,134 -14.7% 27.58 USD 996,738	36,134 -14.7%	27.58	USD 996,738
2019-06-03	2019-05-30	PS Planned sale	Sandor Victor Chief Medical Officer	15,728 -7.0% 27.50 USD 432,520	15,728 -7.0%	27.50	USD 432,520
2019-05-28	2019-05-28	PS Planned sale	Sandor Victor Chief Medical Officer	74,915 -26.3% 27.00 USD 2,022,930	74,915 -26.3%	27.00	USD 2,022,930
2019-05-28	2019-05-23	PS Planned sale	Sandor Victor Chief Medical Officer	40,634 -14.6% 26.50 USD 1,076,846	40,634 -14.6%	26.50	USD 1,076,846
2019-05-23	2019-05-21	PS Planned sale	Sandor Victor Chief Medical Officer	12,600 -5.0% 26.50 USD 333,900	12,600 -5.0%	26.50	USD 333,900
2019-02-21	2019-02-19	B Purchase	COX CARRIE SMITH	5,000 +166.7% 23.20 USD 115,998	5,000 +166.7%	23.20	USD 115,998
2019-02-08	2019-02-07	PS Planned sale	Haddock Jason CFO	85,000 -73.9% 22.05 USD 1,874,301	85,000 -73.9%	22.05	USD 1,874,301
2019-02-08	2019-02-07	PS Planned sale	Squarer Ron CEO	110,000 -31.5% 21.64 USD 2,380,015	110,000 -31.5%	21.64	USD 2,380,015
2019-02-08	2019-02-07	PS Planned sale	Saccomano Nicholas A CSO	187,264 -56.8% 21.58 USD 4,041,756	187,264 -56.8%	21.58	USD 4,041,756
2019-02-08	2019-02-06	PS Planned sale	Haddock Jason CFO	11,712 -28.0% 20.00 USD 234,240	11,712 -28.0%	20.00	USD 234,240
2019-02-08	2019-02-06	S Sale	LEFKOFF KYLE	5,000 -20.0% 20.85 USD 104,261	5,000 -20.0%	20.85	USD 104,261
2019-02-08	2019-02-06	S Sale	LEFKOFF KYLE	5,000 -16.7% 20.82 USD 104,121	5,000 -16.7%	20.82	USD 104,121
2019-02-08	2019-02-06	S Sale	LEFKOFF KYLE	25,000 -52.4% 20.51 USD 512,693	25,000 -52.4%	20.51	USD 512,693
2019-02-08	2019-02-06	S Sale	Robbins Andrew R COO	239,626 -80.0% 20.03 USD 4,798,511	239,626 -80.0%	20.03	USD 4,798,511
2019-02-07	2019-02-05	PS Planned sale	Oltmans Curtis Gale General Counsel	40,000 -72.7% 20.00 USD 800,000	40,000 -72.7%	20.00	USD 800,000
2019-02-01	2019-01-31	PS Planned sale	Squarer Ron CEO	113,438 -32.2% 18.53 USD 2,101,541	113,438 -32.2%	18.53	USD 2,101,541
2019-02-01	2019-01-30	PS Planned sale	Squarer Ron CEO	100,000 -29.5% 18.25 USD 1,825,370	100,000 -29.5%	18.25	USD 1,825,370
2019-01-29	2019-01-25	PS Planned sale	Oltmans Curtis Gale General Counsel	14,029 -78.2% 18.00 USD 252,523	14,029 -78.2%	18.00	USD 252,523
2019-01-23	2019-01-18	PS Planned sale	Oltmans Curtis Gale General Counsel	1,251 -24.2% 18.00 USD 22,518	1,251 -24.2%	18.00	USD 22,518
2019-01-17	2019-01-15	PS Planned sale	Oltmans Curtis Gale General Counsel	19,720 -83.4% 18.06 USD 356,139	19,720 -83.4%	18.06	USD 356,139
2019-01-02	2018-12-27	PS Planned sale	Sandor Victor Chief Medical Officer	6,268 -2.7% 14.05 USD 88,091	6,268 -2.7%	14.05	USD 88,091
2018-12-06	2018-12-03	PS Planned sale	Sandor Victor Chief Medical Officer	115,185 -34.1% 16.21 USD 1,867,045	115,185 -34.1%	16.21	USD 1,867,045
2018-11-05	2018-11-01	B Purchase	COX CARRIE SMITH	3,000 +inf% 16.87 USD 50,595	3,000 +inf%	16.87	USD 50,595
2018-09-21	2018-09-19	PS Planned sale	VAN LUNSEN GIL J	18,000 -48.3% 14.76 USD 265,684	18,000 -48.3%	14.76	USD 265,684
2018-09-05	2018-09-04	PS Planned sale	Sandor Victor Chief Medical Officer	9,687 -4.4% 15.38 USD 148,938	9,687 -4.4%	15.38	USD 148,938
2018-08-17	2018-08-15	PS Planned sale	Haddock Jason CFO	20,000 -36.1% 13.92 USD 278,400	20,000 -36.1%	13.92	USD 278,400
2018-08-17	2018-08-15	PS Planned sale	VAN LUNSEN GIL J	21,500 -52.7% 13.92 USD 299,280	21,500 -52.7%	13.92	USD 299,280
2018-07-31	2018-07-30	PS Planned sale	Haddock Jason CFO	25,000 -31.1% 14.87 USD 371,750	25,000 -31.1%	14.87	USD 371,750
2018-07-19	2018-07-18	PS Planned sale	VAN LUNSEN GIL J	21,500 -52.7% 16.56 USD 356,040	21,500 -52.7%	16.56	USD 356,040
2018-07-06	2018-07-06	S Sale	LEFKOFF KYLE Non-Executive Director	50,000 -73.8% 17.45 USD 872,500	50,000 -73.8%	17.45	USD 872,500
2018-06-29	2018-06-27	PS Planned sale	Robbins Andrew R COO	17,964 -10.1% 17.74 USD 318,681	17,964 -10.1%	17.74	USD 318,681
2018-06-29	2018-06-27	PS Planned sale	Squarer Ron CEO	140,625 -39.9% 18.03 USD 2,535,469	140,625 -39.9%	18.03	USD 2,535,469
2018-06-29	2018-06-27	PS Planned sale	Squarer Ron CEO	43,628 -17.1% 17.74 USD 773,961	43,628 -17.1%	17.74	USD 773,961
2018-06-21	2018-06-20	PS Planned sale	VAN LUNSEN GIL J	21,500 -52.7% 19.08 USD 410,220	21,500 -52.7%	19.08	USD 410,220
2018-06-21	2018-06-19	PS Planned sale	Sandor Victor Chief Medical Officer	77,576 -27.0% 18.76 USD 1,455,326	77,576 -27.0%	18.76	USD 1,455,326
2018-06-15	2018-06-13	PS Planned sale	Sandor Victor Chief Medical Officer	22,424 -9.6% 18.75 USD 420,450	22,424 -9.6%	18.75	USD 420,450
2018-05-17	2018-05-16	PS Planned sale	VAN LUNSEN GIL J Non-Executive Director	21,500 -52.7% 15.36 USD 330,259	21,500 -52.7%	15.36	USD 330,259
2018-04-18	2018-04-18	PS Planned sale	VAN LUNSEN GIL J	21,500 -52.7% 15.19 USD 326,585	21,500 -52.7%	15.19	USD 326,585
2018-04-03	2018-04-03	PS Planned sale	Sandor Victor Chief Medical Officer	8,689 -4.0% 15.35 USD 133,376	8,689 -4.0%	15.35	USD 133,376
2018-03-21	2018-03-21	PS Planned sale	VAN LUNSEN GIL J	21,500 -52.7% 16.76 USD 360,340	21,500 -52.7%	16.76	USD 360,340
2018-03-09	2018-03-09	PS Planned sale	Sandor Victor Chief Medical Officer	111,518 -33.9% 17.72 USD 1,976,099	111,518 -33.9%	17.72	USD 1,976,099
2018-03-09	2018-03-09	PS Planned sale	Sandor Victor Chief Medical Officer	44,498 -11.9% 17.70 USD 787,615	44,498 -11.9%	17.70	USD 787,615
2018-02-23	2018-02-21	PS Planned sale	VAN LUNSEN GIL J	21,500 -52.7% 17.16 USD 368,940	21,500 -52.7%	17.16	USD 368,940
2018-02-12	2018-02-09	S Sale	BAUM CHARLES M	50,000 -83.3% 16.90 USD 845,000	50,000 -83.3%	16.90	USD 845,000
2018-02-12	2018-02-09	S Sale	LEFKOFF KYLE	50,000 -73.8% 17.01 USD 850,500	50,000 -73.8%	17.01	USD 850,500
2018-01-17	2018-01-17	PS Planned sale	VAN LUNSEN GIL J	21,500 -52.7% 12.94 USD 278,210	21,500 -52.7%	12.94	USD 278,210
2018-01-16	2018-01-16	PS Planned sale	Haddock Jason CFO	7,500 -20.6% 13.73 USD 102,975	7,500 -20.6%	13.73	USD 102,975
2017-12-19	2017-12-19	PS Planned sale	Squarer Ron CEO	546,233 -72.3% 10.93 USD 5,970,327	546,233 -72.3%	10.93	USD 5,970,327
2017-12-19	2017-12-18	PS Planned sale	Squarer Ron CEO	273,438 -56.6% 10.73 USD 2,933,990	273,438 -56.6%	10.73	USD 2,933,990
2017-12-19	2017-12-18	PS Planned sale	Robbins Andrew R COO	282,874 -64.1% 10.72 USD 3,032,409	282,874 -64.1%	10.72	USD 3,032,409
2017-09-29	2017-09-29	S Sale	LEFKOFF KYLE	38,865 -75.3% 12.31 USD 478,428	38,865 -75.3%	12.31	USD 478,428
2017-09-29	2017-09-29	S Sale	VAN LUNSEN GIL J	39,928 -72.3% 12.36 USD 493,510	39,928 -72.3%	12.36	USD 493,510
2017-04-04	2017-03-31	S Sale	LEFKOFF KYLE	45,000 -87.2% 8.92 USD 401,400	45,000 -87.2%	8.92	USD 401,400
2017-03-30	2017-03-28	S Sale	BAUM CHARLES M	25,000 -83.3% 9.27 USD 231,750	25,000 -83.3%	9.27	USD 231,750
2016-09-30	2016-09-28	S Sale	Redmile Group, LLC Large shareholder	2,492,578 -13.0% 6.36 USD 15,852,796	2,492,578 -13.0%	6.36	USD 15,852,796
2016-09-16	2016-09-15	B Purchase	Redmile Group, LLC Large shareholder	28,000 +0.1% 3.50 USD 98,000	28,000 +0.1%	3.50	USD 98,000
2016-09-16	2016-09-15	S Sale	Redmile Group, LLC Large shareholder	7,300 -0.0% 3.54 USD 25,842	7,300 -0.0%	3.54	USD 25,842
2016-09-16	2016-09-14	B Purchase	Redmile Group, LLC Large shareholder	372,000 +2.0% 3.51 USD 1,305,720	372,000 +2.0%	3.51	USD 1,305,720
2016-09-16	2016-09-14	S Sale	Redmile Group, LLC Large shareholder	392,700 -2.1% 3.50 USD 1,374,450	392,700 -2.1%	3.50	USD 1,374,450
2016-01-22	2016-01-20	B Purchase	Redmile Group, LLC Large shareholder	300,000 +1.6% 3.19 USD 957,000	300,000 +1.6%	3.19	USD 957,000
2016-01-14	2016-01-12	B Purchase	Redmile Group, LLC Large shareholder	75,000 +0.4% 3.60 USD 270,000	75,000 +0.4%	3.60	USD 270,000
2016-01-11	2016-01-11	B Purchase	Redmile Group, LLC Large shareholder	275,000 +1.5% 3.54 USD 973,500	275,000 +1.5%	3.54	USD 973,500
2016-01-11	2016-01-08	B Purchase	Redmile Group, LLC Large shareholder	350,000 +1.9% 3.72 USD 1,302,000	350,000 +1.9%	3.72	USD 1,302,000
2016-01-11	2016-01-07	B Purchase	Redmile Group, LLC Large shareholder	300,000 +1.7% 3.73 USD 1,119,000	300,000 +1.7%	3.73	USD 1,119,000
2015-10-01	2015-10-01	B Purchase	Redmile Group, LLC Large shareholder	100,140 +0.6% 4.50 USD 450,630	100,140 +0.6%	4.50	USD 450,630
2015-10-01	2015-09-30	B Purchase	Redmile Group, LLC Large shareholder	182,452 +1.0% 4.67 USD 852,051	182,452 +1.0%	4.67	USD 852,051
2015-10-01	2015-09-29	B Purchase	Redmile Group, LLC Large shareholder	500,000 +2.9% 4.56 USD 2,280,000	500,000 +2.9%	4.56	USD 2,280,000
2015-08-28	2015-08-26	B Purchase	Redmile Group, LLC Large shareholder	49,900 +0.3% 5.48 USD 273,452	49,900 +0.3%	5.48	USD 273,452
2015-08-25	2015-08-25	B Purchase	Redmile Group, LLC Large shareholder	220,000 +1.3% 5.45 USD 1,199,000	220,000 +1.3%	5.45	USD 1,199,000
2015-08-25	2015-08-24	B Purchase	Redmile Group, LLC Large shareholder	410,000 +2.5% 5.32 USD 2,181,200	410,000 +2.5%	5.32	USD 2,181,200
2015-08-25	2015-08-21	B Purchase	Redmile Group, LLC Large shareholder	160,000 +1.0% 5.45 USD 872,000	160,000 +1.0%	5.45	USD 872,000
2015-08-13	2015-08-12	B Purchase	Redmile Group, LLC Large shareholder	205,000 +1.3% 5.93 USD 1,215,650	205,000 +1.3%	5.93	USD 1,215,650
2015-08-13	2015-08-11	B Purchase	Redmile Group, LLC Large shareholder	327,500 +2.1% 5.85 USD 1,915,875	327,500 +2.1%	5.85	USD 1,915,875
2015-08-10	2015-08-10	B Purchase	Redmile Group, LLC Large shareholder	180,000 +1.1% 5.81 USD 1,045,800	180,000 +1.1%	5.81	USD 1,045,800

Array BioPharma Inc (ARRY)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by